SZ 133 (Voriconazole 200 mg)
Pill imprint SZ 133 has been identified as Voriconazole 200 mg.
Voriconazole is used in the treatment of aspergillosis, invasive; cutaneous fungal infection; fungal infection, internal and disseminated; coccidioidomycosis, meningitis; candidemia (and more), and belongs to the drug class azole antifungals. There is positive evidence of human fetal risk during pregnancy. Voriconazole 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- SZ 133
- 200 mg
- Prescription only
- Drug Class:
- Azole antifungals
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Sandoz Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
|NDC Code||Manufacturer / Repackager|
|63739-0707||McKesson Packaging Services|
Note: Inactive ingredients may vary.
More about voriconazole
- Voriconazole suspension
- Voriconazole tablets
- Voriconazole (Advanced Reading)
- Voriconazole Oral, Intravenous (Advanced Reading)
- Other brands: Vfend
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.